Real-time enrollment status for this hpv-negative squamous cell carcinoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:34 PM UTC
| NCT Number | NCT06005324 |
| Recruiting Status | Recruiting |
| Condition | HPV-Negative Squamous Cell Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 36 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Chicago |
| Last Updated on CT.gov | June 8, 2025 (Jun 8, 2025) |
As of October 12, 2026: Clinical trial NCT06005324 is currently recruiting participants. This phase1 study for hpv-negative squamous cell carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Chicago. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06005324 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06005324 was last updated Jun 8, 2025 (June 8, 2025). HelloStudys verifies this status automatically.